ArticleBMC cardiovascular disorders2026
Identification and verification of diagnostic biomarkers related to endoplasmic reticulum stress for atherosclerosis.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atherosclerotic Cell Fates: A Single-Cell View of ER Stress.Journal of cardiovascular development and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundEndoplasmic reticulum stress (ERS) is linked to the progression of atherosclerosis (AS). The function of ERS-related genes (ERSRGs) in AS remains ambiguous, hence, this study sought to examined their association with AS.
methodsDatasets relevant to AS were acquired from the Gene Expression Omnibus (GEO) database. Initially, differentially expressed genes (DEGs) were identified between AS and controls. Weighted gene co-expression network analysis (WGCNA) derived AS-related module genes. The intersection of DEGs, AS-related module genes, and ERSRGs was subsequently evaluated by three machine learning algorithms. After processing expression analysis and receiver operating characteristic (ROC) curve evaluation, biomarkers were ultimately found. A nomogram was developed and validated to predict the incidence of AS based on biomarkers. Finally, single cell RNA sequencing (scRNA-seq) analysis was utilized to identify distinct cell subpopulations, followed by cell communication and pseudotime analysis.
resultsANKRD1, BDNF, HLA-B, NLRP3, NOD2, and XAF1 were recognized as biomarkers for AS. The nomogram developed using biomarkers demonstrated exceptional efficacy in predicting AS occurrence. The scRNA-seq analysis annotated 6 cell subpopulations, including NK cells, B cells, T cells, vascular smooth muscle cells (VSMCs), endothelial, and macrophages. VSMCs exhibited increased communication in AS samples compared to control samples. Moreover, we noted that HLA-B exhibited elevated expression during the prophase and anaphase of VSMCs differentiation, whereas XAF1 had increased expression in the later stages of VSMCs differentiation.
conclusionThis study found 6 biomarkers (ANKRD1, BDNF, HLA-B, NLRP3, NOD2, and XAF1) associated with ERS in AS, providing novel diagnostic targets for the condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.